Skip to main content

Table 3 Outcomes of 6 dogs that underwent deroofing +/− omentalization

From: Perioperative characteristics, histologic diagnosis, complications, and outcomes of dogs undergoing percutaneous drainage, sclerotherapy or surgical management of intrarenal cystic lesions: 18 dogs (2004–2021)

Dog number

Histologic diagnosis

Previous treatment

Clinical signs related to ICL at FUa

Resolution of preprocedural clinical signs at last FUa

Progression in size of treated ICL(s) at last FU imaginga

Azotemia pre-procedure

Azotemia on FU biochemistrya

Additional treatment performed

Dead, alive, LTFU post treatment

5

Cystadenocarcinoma

Sclerotherapy (530 days), PCD (241 days)

Decreased appetite (202 days)

No

NP

Yes

Yes but improved (18 days)

No

Died, unknown cause

(202 days; 732 days post index treatment)

7

Renal cyst

NP

No

(44 days)

N/A

28% its original size

(44 days)

No

No

(13 days)

No

LTFU

(44 days post index treatment)

10

Renal adenoma

PCD performed twice (81 days and 42 days), Sclerotherapy (24 days)

No

(325 days)

Not available

62.5% its original size (325 days)

NP

No

(325 days)

No

Alive

(325 days; 406 days post index treatment)

12

Renal cyst

NP

No

(619 days)

Yes

Resolved

(61 days)

No

No

(61 days)

No

Alive

(619 days post index treatment)

14

Renal cyst

NP

No

(308 days)

N/A

Resolved

(51 days)

Yes

Yes, worsening (51 days)

No

Alive

(308 days post index treatment)

18

Renal cyst

NP

No

(45 days)

Yes

Resolved

(45 days)

Yes

Yes,

improving (45 days)

No

Alive

(45 days post index treatment)

  1. Days presented in parenthesis are calculated from the date of the deroofing +/− omentalization
  2. FU follow-up, LTFU lost to follow-up, N/A not applicable, NP not performed
  3. aDenotes date of last follow-up after deroofing +/− omentalization